866-997-4948(US-Canada Toll Free)

Hypercholesterolemia Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Sep 2017

Category :

Pharmaceutical

No. of Pages : 770 Pages

Hypercholesterolemia Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Hypercholesterolemia Global Clinical Trials Review, H2, 2017" provides an overview of Hypercholesterolemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercholesterolemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hypercholesterolemia Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Hypercholesterolemia 30
Sep 19, 2017: Gemphire Announces Plans to Advance Gemcabene into Phase 3 Clinical Development 30
Aug 28, 2017: New, One-Year Data from ORION-1 Phase II Study of Inclisiran Extends Excellent Long-Term Efficacy and Safety Profile, Affirming Dose for Phase III Trials 31
Aug 25, 2017: Regeneron and Sanofi to Present New Analyses from Praluent Injection Trials at the ESC Congress 2017 32
Aug 21, 2017: Amgen To Present New Data From The Repatha (Evolocumab) Cardiovascular Outcomes Study At ESC Congress 2017 33
Aug 16, 2017: Repatha (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine 34
Aug 08, 2017: Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin 35
Aug 07, 2017: Gemphire Announces Top-Line Data from ROYAL-1 Phase 2b Clinical Trial in Hypercholesterolemic Patients 35
Jul 26, 2017: Esperion Announces Initiation of Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor 36
Clinical Trial Profile Snapshots 37
Appendix 768
Abbreviations 768
Definitions 768
Research Methodology 769
Secondary Research 769
About GlobalData 770
Contact Us 770
Source 770

List of Tables
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Region, 2017* 7
Hypercholesterolemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Hypercholesterolemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Hypercholesterolemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Hypercholesterolemia Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Hypercholesterolemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
Hypercholesterolemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 15
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 18
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Hypercholesterolemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Hypercholesterolemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Hypercholesterolemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Hypercholesterolemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Hypercholesterolemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Hypercholesterolemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Hypercholesterolemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Hypercholesterolemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Hypercholesterolemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Hypercholesterolemia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Hypercholesterolemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Hypercholesterolemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 15
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 18
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Hypercholesterolemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Hypercholesterolemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Hypercholesterolemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Hypercholesterolemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Hypercholesterolemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Hypercholesterolemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 769

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *